USPTO serial 77647976
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Extended release capsules and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension and Tourette's syndrome | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 3, 2009 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Aug 3, 2009 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jul 1, 2009 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 4, 2009 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 5, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 27, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 27, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 27, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 16, 2009 | NWAP | NEW APPLICATION ENTERED | — |